Teva Pharmaceutical Industries Ltd (TEVA)

2,680
-3(-0.11%)
  • Volume:
    2,058,002
  • Bid/Ask:
    2,680/2,684
  • Day's Range:
    2,624 - 2,697
  • Type:Equity
  • Market:Israel
  • ISIN:IL0006290147
  • S/N:629014

TEVA Overview

Prev. Close
2,683
Day's Range
2,624-2,697
Revenue
51.81B
Open
2,630
52 wk Range
2,624-4,390
EPS
2.07
Volume
2,058,002
Market Cap
29.56B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,702,656
P/E Ratio
12.94
Beta
1.45
1-Year Change
-16.16%
Shares Outstanding
1,103,007,168
Next Earnings Date
Feb 10, 2022
What is your sentiment on Teva Pharmaceutical Industries Ltd?
or
Market is currently closed. Voting is open during market hours.

Teva Pharmaceutical Industries Ltd Company Profile

Employees
37736
Market
Israel

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company’s products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell S.A. to develop mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Sell
SummaryStrong BuyBuySellStrong SellStrong Sell
  • asdfasdfadf investing
    0
    • google <a href="https://www.google.com"> google </a>
      0
      • nice move against nasdaq on last friday
        0
        • hello Associates & Partners I sold at 10.45 $ and now I am looking to entry in NGM , MYOVANT or MERSANA what which is your impact and your opinion which equity will go better for short term? please if anybody knows let me know your precious feedback, Szilike.
          0
          • good news. teva will sell malaria cure against the corrona virus
            1
            • Yes
              0
            • 0
            • 0
          • when the Dow drops 900 points and Teva is up, that's a really good sign of strength.
            0
            • buy?
              0
              • Yep, they have the main drug to treat the plague, and they are already restructured and doing well.
                0
            • buy?
              0
              • after 3 long hard years, TEVA is finally found the bottom.. better years ahead for the company and the stock. this will be one mighty comeback! "a wounded lion is still a lion"...
                0
                • even if he offeres the lioness a ***
                  0
              • Pe of 3, that is cheap !! End Aug court judgement in USA.trump will influence the judge to be lenient, fine $900 mln, and stock will double.
                0
                • not sure he has enough power to influence on court
                  0
              • !!
                1
                • it looks good
                  0
                  • lol
                    0
                • is it good to buy here??
                  0
                  • Yes. Obviously... but only as a long term investment...
                    0
                  • Yes. Obviously... but only as a long term investment...
                    0
                • The same rollercoaster
                  0
                  • Going down
                    1
                    • Terrible performance vs. Expectation to atleast follow
                      0
                  • Test
                    2
                    • ok
                      0
                  • Test
                    3
                    • Ok
                      0
                  • Test
                    1
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.